These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3447445)

  • 1. Middle molecules and the 7 C factor.
    Bergström J; Jörnvall H; Zimmerman L
    Adv Exp Med Biol; 1987; 223():27-32. PubMed ID: 3447445
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for separation of middle molecules by high performance liquid chromatography: application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects.
    Zimmerman L; Bergström J; Jörnvall H
    Clin Nephrol; 1986 Feb; 25(2):94-100. PubMed ID: 3698350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of salsalate in normal subjects.
    Dromgoole SH; Furst DE; Paulus HE
    J Pharm Sci; 1984 Nov; 73(11):1657-9. PubMed ID: 6520777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and protein binding of salicylate metabolites in rats.
    Morris ME
    Drug Metab Dispos; 1990; 18(5):809-11. PubMed ID: 1981740
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What remains of the "middle molecule" hypothesis today?
    Brunner H; Mann H
    Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
    [No Abstract]   [Full Text] [Related]  

  • 8. Retention patterns.
    Schoots A; Vanholder R; Ringoir S; Cramers C
    Adv Exp Med Biol; 1987; 223():19-26. PubMed ID: 3447434
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a double conjugate in uremic body fluids.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    FEBS Lett; 1981 Jul; 129(2):237-40. PubMed ID: 7286217
    [No Abstract]   [Full Text] [Related]  

  • 10. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 11. Middle molecules in uraemia.
    Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
    Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
    [No Abstract]   [Full Text] [Related]  

  • 12. Separation of one uremic middle molecules fraction by high performance liquid chromatography.
    Gallice P; Fournier N; Crevat A; Briot M; Frayssinet R; Murisasco A
    Kidney Int; 1983 May; 23(5):764-6. PubMed ID: 6876571
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 15. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a 1100-1300 MW uremic neurotoxin.
    Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
    Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved separation and quantification of the "middle molecule" b4-2 in uremia.
    Faguer P; Man NK; Cueille G; Di Giulio S; Funck-Brentano JL
    Clin Chem; 1983 Apr; 29(4):703-7. PubMed ID: 6831703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 19. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged blood concentration of salicylic acid following the simultaneous oral administration of salicylic acid and salicyluric acid in rabbits.
    Nakamura J; Inoue Y; Sasaki H; Shibasaki J
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2624-7. PubMed ID: 3769078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.